References
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69:7–34.
- Seo GH, Choe EK, Park KJ, et al. Incidence of clinically relevant incisional hernia after colon cancer surgery and its risk factors: a nationwide claims study. World J Surg. 2018;42:1192–1199.
- Sun YH, Li J, Shu HJ, et al. Serum immunoinflammation-related protein complexes discriminate between inflammatory bowel disease and colorectal cancer. Clin Transl Oncol. 2019;21:1680–1686.
- Smith JJ, Deane NG, Wu F, et al. Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer. Gastroenterology. 2010;138:958–968.
- Lin C-P, He L. Noncoding RNAs in cancer development. Ann Rev Cancer Biol. 2017;1:163–184.
- Derrien T, Johnson R, Bussotti G, et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res. 2012;22:1775–1789.
- Yang X, Ikhwanuddin M, Li X, et al. Comparative transcriptome analysis provides insights into differentially expressed genes and long non-coding RNAs between ovary and testis of the mud crab (scylla paramamosain). Mar Biotechnol (NY). 2018;20:20–34.
- Ulitsky I, Bartel DP. lincRNAs: genomics, evolution, and mechanisms. Cell. 2013;154(1):26–46.
- Zhang Y, Fang Z, Guo X, et al. lncRNA B4GALT1-AS1 promotes colon cancer cell stemness and migration by recruiting YAP to the nucleus and enhancing YAP transcriptional activity. J Cell Physiol. 2019;234:18524–18534.
- Zhang W, Yuan W, Song J, et al. LncRNA CPS1-IT1 suppresses EMT and metastasis of colorectal cancer by inhibiting hypoxia-induced autophagy through inactivation of HIF-1alpha. Biochimie. 2018;144:21–27.
- Wilhelm A, Jahns F, Bocker S, et al. Culturing explanted colon crypts highly improves viability of primary non-transformed human colon epithelial cells. Toxicol In Vitro. 2012;26:133–141.
- Habano W, Gamo T, Terashima J, et al. Involvement of promoter methylation in the regulation of Pregnane X receptor in colon cancer cells. BMC Cancer. 2011;11:81.
- Stueve TR, Li WQ, Shi J, et al. Epigenome-wide analysis of DNA methylation in lung tissue shows concordance with blood studies and identifies tobacco smoke-inducible enhancers. Hum Mol Genet. 2017;26:3014–3027.
- Mann M, Wright PR, Backofen R. IntaRNA 2.0: enhanced and customizable prediction of RNA-RNA interactions. Nucleic Acids Res. 2017;45:W435–W9.
- Ma J, Matkar S, He X, et al. FOXO family in regulating cancer and metabolism. Semin Cancer Biol. 2018;50:32–41.
- Erdmann A, Menon Y, Gros C, et al. Design and synthesis of new non nucleoside inhibitors of DNMT3A. Bioorg Med Chem. 2015;23:5946–5953.
- Ramaswamy S, Nakamura N, Sansal I, et al. A novel mechanism of gene regulation and tumor suppression by the transcription factor FKHR. Cancer Cell. 2002;2:81–91.
- Lee SY, Lee GR, Woo DH, et al. Depletion of Aurora A leads to upregulation of FoxO1 to induce cell cycle arrest in hepatocellular carcinoma cells. Cell Cycle. 2013;12:67–75.
- Yan L, Lavin VA, Moser LR, et al. PP2A regulates the pro-apoptotic activity of FOXO1. J Biol Chem. 2008;283:7411–7420.
- Chae YC, Kim JY, Park JW, et al. FOXO1 degradation via G9a-mediated methylation promotes cell proliferation in colon cancer. Nucleic Acids Res. 2019;47:1692–1705.
- Kitano H. Towards a theory of biological robustness. Mol Syst Biol. 2007;3:137.
- Gutierrez-Arcelus M, Lappalainen T, Montgomery SB, et al. Passive and active DNA methylation and the interplay with genetic variation in gene regulation. Elife. 2013;2:e00523.
- Chauvier D, Morjani H, Manfait M. Ceramide involvement in homocamptothecin- and camptothecin-induced cytotoxicity and apoptosis in colon HT29 cells. Int J Oncol. 2002;20:855–863.
- Yu J, Wang Z, Kinzler KW, et al. PUMA mediates the apoptotic response to p53 in colorectal cancer cells. Proc Natl Acad Sci U S A. 2003;100:1931–1936.
- Li L, Lin L, Li M, et al. Gilteritinib induces PUMA-dependent apoptotic cell death via AKT/GSK-3beta/NF-kappaB pathway in colorectal cancer cells. J Cell Mol Med. 2020;24:2308–2318.